CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Wake Forest University School of Medicine Develops Digital Platform to Better Care for Stroke Patients
News | 08. 09. 2022
August 9, 2022: Pappas managed Catalyst Fund provides funding to develop Wake Forest University School of Medicine digital platform.
